Schedule 13G ownership disclosure
Rhythm Pharmaceuticals Inc
Common Stock, $0.001 par value per share · CUSIP: 76243J105
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 4,423,441 · Class: 6.8%
- Joseph Edelman
Shares: 4,423,441 · Class: 6.8%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 2,965,121 · Class: 4.5%
- Perceptive Discovery ID LP
Shares: 1,458,330 · Class: 2.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072947
- Form type
- SCHEDULE 13G/A
- Filer
- PERCEPTIVE ADVISORS LLC
- CIK
- CIK 1224962
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership